(Q46373110)

21 December 2017

title

Lipid-based amphotericin in pulmonary zygomycosis: safety and efficacy of high exposure in a renal allograft recipient (English)

1 reference

21 December 2017

1 reference

Crompton JA

1

1 reference

21 December 2017

Alexander D

series ordinal

2

1 reference

21 December 2017

Somerville T

series ordinal

3

1 reference

21 December 2017

Shihab FS

series ordinal

4

1 reference

21 December 2017

publication date

1 December 2004

1 reference

21 December 2017

Transplant Infectious Disease

published in

1 reference

21 December 2017

volume

6

1 reference

21 December 2017

issue

4

1 reference

21 December 2017

page(s)

183-187

1 reference

21 December 2017

Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. GIMEMA Infection Program (Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto).

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2004.00076.X

Pulmonary mucormycosis: the last 30 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2004.00076.X

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2004.00076.X

A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2004.00076.X

Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2004.00076.X

Risk factors for amphotericin B-induced nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2004.00076.X

Plasma protein binding of amphotericin B and pharmacokinetics of bound versus unbound amphotericin B after administration of intravenous liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2004.00076.X

Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2004.00076.X

AmBisome: liposomal formulation, structure, mechanism of action and pre-clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2004.00076.X

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2004.00076.X

Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2004.00076.X

Continuous infusion of escalated doses of amphotericin B deoxycholate: an open-label observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2004.00076.X

Continuous and 4 h infusion of amphotericin B: a comparative study involving high-risk haematology patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2004.00076.X

The solubility ceiling: a rationale for continuous infusion amphotericin B therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2004.00076.X

In vitro susceptibilities of zygomycetes to conventional and new antifungals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2004.00076.X

In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2004.00076.X

10.1111/J.1399-3062.2004.00076.X

21 January 2018

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017